SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-100626
Filing Date
2005-05-09
Accepted
2005-05-09 14:13:39
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 1698321
2 CONSENT OF ERNST & YOUNG LLP, IND REGISTERED PUBLIC ACCTING FIRM dex231.htm EX-23.1 2659
3 CERTIFICATION OF PEO REQUIED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7287
4 CERTIFICATION OF PFO REQUIED BY RULE 13A-14(A) OR RULE 5D-14(A) dex312.htm EX-31.2 7420
5 SECTION 1350 CERTIFICATIONS dex321.htm EX-32.1 5422
  Complete submission text file 0001193125-05-100626.txt   1722704
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-24006 | Film No.: 05811003
SIC: 2834 Pharmaceutical Preparations